Tuesday, July 05, 2016 3:35:44 PM
CHEK...asked StockCharts.com 3 times to make a chart available for CHEK...
This would mean no more sygmoidoscopies...see post replying to...
Analysts have set a twelve-month consensus price target of $8.50 for the company. http://www.sfhfm.org/zacks-check-cap-ltd-nasdaqchek-given-8-50-consensus-target-price-by-brokerages/
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the screening for precancerous polyps and cancer. Its product include ingestible capsule with a colon imaging system for colorectal cancer and pre-cancerous polyps that utilizes X-ray-based technology to generate 3-dimensional imagery of the colon without cleansing or other aggressive bowel preparation. The company was founded in 2004 and is headquartered in Mount Carmel, Israel.
Daily...
CHEK
This would mean no more sygmoidoscopies...see post replying to...
Analysts have set a twelve-month consensus price target of $8.50 for the company. http://www.sfhfm.org/zacks-check-cap-ltd-nasdaqchek-given-8-50-consensus-target-price-by-brokerages/
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the screening for precancerous polyps and cancer. Its product include ingestible capsule with a colon imaging system for colorectal cancer and pre-cancerous polyps that utilizes X-ray-based technology to generate 3-dimensional imagery of the colon without cleansing or other aggressive bowel preparation. The company was founded in 2004 and is headquartered in Mount Carmel, Israel.
Daily...
CHEK
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
